Stocks and Investing Stocks and Investing
Wed, November 3, 2010
Tue, November 2, 2010

CBM, NXST, HBIO, PGTI, INMD, SCMP Expected To Be Down After Next Earnings Releases


Published on 2010-11-02 10:08:39, Last Modified on 2010-12-22 19:16:51 - WOPRAI
  Print publication without navigation


November 2, 2010 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Wednesday, November 3rd 2010 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and November earnings reports. CAMBREX CORP (NYSE:CBM), NEXSTAR BROADCASTING GROUP-A (NASDAQ:NXST), HARVARD BIOSCIENCE INC (NASDAQ:HBIO), PGT INC (NASDAQ:PGTI), INTEGRAMED AMERICA INC (NASDAQ:INMD), SUCAMPO PHARMACEUTICALS-CL A (NASDAQ:SCMP) are all expected to be Down After their earnings are released Wednesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Wednesday:

     Symbol     Company                         # of Reports            Quarter     Release Time
     CBM        CAMBREX CORP                    12 Quarter              Q3           After
     NXST       NEXSTAR BROADCASTING GROUP-A     12 Quarter              Q3           Before
     HBIO       HARVARD BIOSCIENCE INC          12 Quarter              Q3           Before
     PGTI       PGT INC                         12 Quarter              Q3           After
     INMD       INTEGRAMED AMERICA INC          November Earnings       Q3           Before
     SCMP       SUCAMPO PHARMACEUTICALS-CL A     12 Quarter              Q3           After

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

CAMBREX CORP (NYSE:CBM) - Cambrex Corporation, a life sciences company, provides products and services for the development and commercialization of new and generic therapeutics. Its products include active pharmaceutical ingredients and pharmaceutical intermediates for use in the production of prescription and over-the-counter drug products, and other custom chemicals derived from organic chemistry. The company sells its products through sales agents and independent agents to pharmaceutical and generic drug companies worldwide. Cambrex Corporation was founded in 1981 and is based in East Rutherford, New Jersey.

NEXSTAR BROADCASTING GROUP-A (NASDAQ:NXST) - Nexstar Broadcasting Group, Inc., a television broadcasting company, engages in the acquisition, development, and operation of television stations in medium-sized markets in the United States. As of December 31, 2009, the company owned and operated 34 stations, and provided sales or other services to an additional 25 stations, which are owned by other entities in 34 markets in the states of New York, Pennsylvania, Illinois, Indiana, Missouri, Texas, Louisiana, Arkansas, Alabama, Utah, Florida, Montana, Rhode Island, and Maryland. In addition, Nexstar Broadcasting, through various local service agreements, provides sales, programming, and other services to stations owned and/or operated by independent third parties. The company was founded in 1996 and is based in Irving, Texas.

HARVARD BIOSCIENCE INC (NASDAQ:HBIO) - Harvard Bioscience, Inc. develops, manufactures, and markets apparatus and scientific instruments used in life science research in pharmaceutical and biotechnology companies, universities, and government laboratories in the United States and internationally. The companys products target ADMET testing, and molecular biology and liquid handling application areas. Its ADMET testing products comprise absorption diffusion chambers that measure the absorption of a drug into the bloodstream; well equilibrium dialysis plates for serum protein binding assays; organ testing systems; infusion pumps for infusing liquids; behavioral products used in neuroscience, cardiology, psychological, and respiratory studies to evaluate the effects of situational stimuli, drugs, and nutritional infusions on motor and sensory, activity, and learning and test behavior; cell injection systems; ventilators; and electroporation products. The company also distributes various devices, instruments, and consumable items used in experiments involving cells, tissues, organs, and animals in the fields of proteomics, physiology, pharmacology, neuroscience, cell biology, molecular biology, and toxicology. It sells its ADMET testing products under the Harvard Apparatus, BTX, KD Scientific, Hugo Sachs Elektronik, Panlab, and Warner Instruments brands names. Its molecular biology and liquid handling products include molecular biology spectrophotometers, DNA/RNA/protein calculators, multi-well plate readers, amino acid analysis systems, liquid dispensers, gel electrophoresis systems, and consumables primarily consisting of pipettes, pipette tips, autoradiography films, gloves, thermal cycler accessories, and reagents. The company sells its products to researchers through catalogs, its Website, and distributors, as well as directly in the United States, the United Kingdom, Germany, France, Spain, and Canada. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.

PGT INC (NASDAQ:PGTI) - PGT, Inc. engages in the manufacture and supply of residential impact-resistant windows and doors. The company offers impact-resistant products, including heavy-duty aluminum or vinyl frames with laminated glass to provide protection from hurricane-force winds and wind-borne debris. It also offers a range of non-impact-resistant aluminum and vinyl frame windows and doors; sliding panels for porch enclosures, such as vinyl-glazed and aluminum-framed products used for enclosing screened-in porches that provide protection from inclement weather; and Architectural Systems line of products, which offer protection from hurricane-force winds and wind-borne debris for mid-and high-rise buildings. The company markets its products under the WinGuard, PremierVue, PGT Architectural Systems, Eze-Breeze, SpectraGuard, and PremierVue brand names. PGT, Inc. offers its products to residential new construction, and home repair and remodeling end markets through window distributors, building supply distributors, window replacement dealers, and enclosure contractors. It operates in the southeastern United States, the Gulf Coast, Central America, Canada, and the Caribbean. The company was founded in 1980 and is headquartered in North Venice, Florida.

INTEGRAMED AMERICA INC (NASDAQ:INMD) - IntegraMed America, Inc., a specialty healthcare services company, manages outpatient centers offering products and services to patients and providers in the fertility and vein care segments of the health industry in the United States. It operates through three divisions: Fertility Centers, Consumer Services, and Vein Clinics. The Fertility Centers division provides business and management services to a network of 14 contracted fertility centers that perform diagnostic tests on women and men to determine the cause of infertility, as well as offer various treatment options, including IVF treatment, frozen embryo transfer, intrauterine insemination, and minimally invasive surgery to correct anatomical reproductive problems. The Consumer Services division offers Attain IVF programs, which are designed to help patients attain their goal of starting a family. It offers these programs directly to fertility patients, including patients of its partner centers and patients of the divisions contracted network of independent medical providers under its affiliate program. As of December 31, 2009, this division maintained a contracted network of 25 independent fertility centers under its affiliate program. The Vein Clinics division provides business and management services to clinics. This division managed a network of 34 clinics in 13 states, which specialize in the treatment of vein disease and other vein disorders. The company was founded in 1985 and is headquartered in Purchase, New York.

SUCAMPO PHARMACEUTICALS-CL A (NASDAQ:SCMP) - Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs based on prostones primarily in the Americas, Europe, and Asia. It offers prostone-based compounds for the treatment of gastrointestinal, vascular, respiratory, and central nervous system diseases and disorders. The company primarily markets Amitiza for the treatment of chronic idiopathic constipation in adults, as well as for irritable bowel syndrome with constipation in adult women. It also offers Rescula (unoprostone isopropyl) for the treatment of open-angle glaucoma and ocular hypertension. In addition, the company is developing Amitiza for the treatment of opioid-induced bowel dysfunction, which completed two Phase III clinical trials; Cobiprostone for the prevention of non-steroidal anti-inflammatory drug induced ulcers, which completed a Phase IIa clinical trial; SPI-017, a Phase I clinical trial product, for the treatment of Peripheral arterial disease; and SPI-3608 for the treatment of spinal stenosis, which is under preclinical trial. Additionally, it is conducting a preclinical trial of Rescula for dry age related macular degeneration; and preclinical trials of Cobiprostone for the treatment of chronic obstructive pulmonary disease and wound healing. Sucampo Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

Contributing Sources